汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300146 汤臣倍健

已收盘 08-08 15:00:00

{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":11.92,"timestamp":1754636625000,"preClose":11.86,"halted":0,"volume":11766552,"delay":0,"changeRate":0.0051,"floatShares":1130000000,"shares":1701000000,"eps":0.293,"marketStatus":"已收盘","change":0.06,"latestTime":"08-08 15:00:00","open":11.88,"high":11.93,"low":11.8,"amount":140000000,"amplitude":0.011,"askPrice":11.92,"askSize":1006,"bidPrice":11.91,"bidSize":279,"shortable":0,"etf":0,"ttmEps":0.293,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754875800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.86,"symbolType":"stock","openAndCloseTimeList":[[1754616600000,1754623800000],[1754629200000,1754636400000]],"highLimit":13.05,"lowLimit":10.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1700845431,"isCdr":false,"pbRate":1.75,"roa":"--","peRate":40.682594,"roe":"4.03%","epsLYR":0.39,"committee":-0.445542,"marketValue":20274000000,"turnoverRate":0.0104,"status":0,"floatMarketCap":13469000000},"requestUrl":"/m/hq/s/300146","defaultTab":"news","newsList":[{"id":"2558657603","title":"图解汤臣倍健中报：第二季度单季净利润同比增71.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558657603","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558657603?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:12","pubTimestamp":1754673164,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健2025年中报显示，公司主营收入35.32亿元，同比下降23.43%；归母净利润7.37亿元，同比下降17.34%；扣非净利润6.93亿元，同比下降16.59%；其中2025年第二季度，公司单季度主营收入17.41亿元，同比下降11.51%；单季度归母净利润2.82亿元，同比上升71.44%；单季度扣非净利润2.85亿元，同比上升133.45%；负债率17.09%，投资收益-1665.26万元，财务费用-960.03万元，毛利率68.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080900000929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146"],"gpt_icon":0},{"id":"2557271695","title":"汤臣倍健公布半年报 上半年净利减少17.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557271695","media":"新浪财经-鹰眼工作室","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557271695?lang=zh_cn&edition=full","pubTime":"2025-08-08 18:50","pubTimestamp":1754650200,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　8月8日消息，汤臣倍健发布半年度报告。　　公告显示，公司半年度营业收入3,532,312,427.79元，同比减少23.43%，归属上市公司股东的净利润736,513,235.60元，同比减少17.34%。　　公告显示，十大流通股东中，山东省国有资产投资控股有限公司为新进流通股东。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-08-08/doc-infkhmtz1869626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","300146","BK0226","BK0107","BK0028","BK0146","BK0042"],"gpt_icon":0},{"id":"2557547961","title":"汤臣倍健上半年营业收入35.32亿元，同比下降23.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557547961","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557547961?lang=zh_cn&edition=full","pubTime":"2025-08-08 17:55","pubTimestamp":1754646926,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0226","300146","BK0042","BK0114","BK0028","BK0107","BK0146"],"gpt_icon":0},{"id":"2557392316","title":"汤臣倍健：2025年围绕“强经营质量提升”核心目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2557392316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557392316?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:24","pubTimestamp":1754400248,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健08月05日在投资者关系平台上答复投资者关心的问题。从机构调研和对中小投资者的互动来看，似乎看不到有什么实质性的进展。想请董秘介绍一下这半年多来公司有哪些可喜的改变？2025年，公司围绕“强经营质量提升”的核心目标，聚焦核心品类的创新升级、全渠道业务提质增效、数字化等重大项目课题，坚定落实各项战略决策。具体内容请关注公司2025年半年度报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080500038038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0028","BK0114","BK0146","BK0042","BK0107","BK0226"],"gpt_icon":0},{"id":"2557394047","title":"汤臣倍健：国内膳食营养补充剂行业仍有广阔的发展空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2557394047","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557394047?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:21","pubTimestamp":1754400070,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健08月05日在投资者关系平台上答复投资者关心的问题。公司主营膳食营养补充剂业务，从人均消费额、整体渗透率、人口老龄化趋势及大健康的政策背景等方面来看，国内膳食营养补充剂行业仍有广阔的发展空间。消费环境的持续变化、消费群体年龄阶层不断扩大使膳食营养补充剂消费需求呈现多样化的发展态势，进一步推动行业向愈发细分化、专业化方向发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080500037968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0028","BK0146","BK0107","BK0114","300146","BK0042"],"gpt_icon":0},{"id":"2555517670","title":"汤臣倍健：公司面向全年龄段消费人群构筑了丰富的品类及品牌矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2555517670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555517670?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:18","pubTimestamp":1753795089,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健07月29日在投资者关系平台上答复投资者关心的问题。公司坚持全球原料品质优势战略，在全球范围内科学甄选优质原料，其中叶黄素进口自瑞士，胡萝卜素进口自澳大利亚。公司面向全年龄段消费人群构筑了丰富的品类及品牌矩阵，主品牌“汤臣倍健”、专业婴童营养品牌“天然博士”下均有相关产品布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900038319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0042","BK0028","BK0226","BK0146","BK0107","300146"],"gpt_icon":0},{"id":"2554076884","title":"汤臣倍健：公司生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2554076884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554076884?lang=zh_cn&edition=full","pubTime":"2025-07-25 17:12","pubTimestamp":1753434729,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，1、公司上半年经营是否正常？2、海外扩展进展如何？3、建议美国、欧洲市场也要进去。汤臣倍健回复：投资者您好！公司生产经营正常。公司持续开拓东南亚核心市场，布局多国多个线下连锁、跨境及本地电商渠道，目前海外业务的体量尚较小。感谢您的建议。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500027813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0107","BK0146","BK0042","BK0226","300146","BK0028"],"gpt_icon":0},{"id":"2553213233","title":"汤臣倍健：公司致力于做大做强主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2553213233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553213233?lang=zh_cn&edition=full","pubTime":"2025-07-23 17:09","pubTimestamp":1753261777,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司目前的发展陷入瓶颈期，轻络素又迟迟没有审批通过，公司是否有打算并购一些好公司，诸如参股一些智能Al机器人企业，医疗器械企业，直播龙头企业，跨境电子商务企业，养老银发产业这些都是属于未来国家重点扶持行业！希望董事局尽快商议，尽快推进，祝公司越来越好！汤臣倍健回复：投资者您好！公司致力于做大做强主业，将结合市场情况及整体战略规划审慎决策投资并购事项。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300028586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300146","BK0146","BK0226","BK0042","BK0114","BK0107"],"gpt_icon":0},{"id":"2553268281","title":"汤臣倍健获得发明专利授权：“一种原花青素C1的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2553268281","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553268281?lang=zh_cn&edition=full","pubTime":"2025-07-23 02:58","pubTimestamp":1753210705,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示汤臣倍健新获得一项发明专利授权，专利名为“一种原花青素C1的制备方法”，专利申请号为CN202311249079.7，授权日为2025年7月22日。今年以来汤臣倍健新获得专利授权29个，较去年同期减少了3.33%。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目46次；财产线索方面有商标信息5466条，专利信息679条，著作权信息51条；此外企业还拥有行政许可849个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300002933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0042","BK0028","BK0226","BK0146","BK0107","300146"],"gpt_icon":0},{"id":"2553734784","title":"汤臣倍健：新生代消费者推动行业向细分化专业化方向发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2553734784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553734784?lang=zh_cn&edition=full","pubTime":"2025-07-21 18:18","pubTimestamp":1753093084,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：你好  想咨询下贵公司如何看待80 90后这批保健品消费者汤臣倍健回复：投资者您好！随着生活方式的转变和健康意识的显著提升，膳食营养补充剂消费群体年龄阶层不断扩大，新生代消费者群体的加入叠加消费观念转型有效扩容膳食营养补充剂市场的整体需求，同时，新生代消费者个性化、多样化的需求推动行业向细分化、专业化方向发展。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100025900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0042","BK0107","BK0028","300146","BK0146","BK0226"],"gpt_icon":0},{"id":"2552469005","title":"汤臣倍健：公司已递交新功能申报目前尚在审批中","url":"https://stock-news.laohu8.com/highlight/detail?id=2552469005","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552469005?lang=zh_cn&edition=full","pubTime":"2025-07-18 18:18","pubTimestamp":1752833901,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月18日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问公司，轻络素历经9年研发，三年送审年，目前的进度如何？这个颠覆全球的发明什么时候才可以造福人类！汤臣倍健回复：投资者您好！公司已递交新功能申报，目前尚在审批中。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800031341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0146","BK0114","BK0226","BK0028","BK0107","BK0042"],"gpt_icon":0},{"id":"2552173395","title":"汤臣倍健新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2552173395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552173395?lang=zh_cn&edition=full","pubTime":"2025-07-17 04:58","pubTimestamp":1752699492,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日汤臣倍健股份有限公司新提交2件商标注册申请。商标申请详情如下：今年以来汤臣倍健股份有限公司新申请注册商标107件，截止目前公司共持有注册商标7918件，另有366件商标尚在注册申请中。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目46次；财产线索方面有商标信息5464条，专利信息679条，著作权信息51条；此外企业还拥有行政许可849个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700002843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300146","BK0146","BK0028","BK0107","BK0042","BK0114"],"gpt_icon":0},{"id":"2550566594","title":"汤臣倍健新提交“SHAPEGLP”等3件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2550566594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550566594?lang=zh_cn&edition=full","pubTime":"2025-07-10 05:07","pubTimestamp":1752095221,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日汤臣倍健股份有限公司新提交“SHAPEGLP”等3件商标注册申请。商标申请详情如下：今年以来汤臣倍健股份有限公司新申请注册商标105件，截止目前公司共持有注册商标7918件，另有364件商标尚在注册申请中。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目46次；财产线索方面有商标信息5463条，专利信息679条，著作权信息51条；此外企业还拥有行政许可849个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000003348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0114","BK0028","300146","BK0226","BK0146","BK0042"],"gpt_icon":0},{"id":"2549315107","title":"汤臣倍健新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2549315107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549315107?lang=zh_cn&edition=full","pubTime":"2025-07-05 05:58","pubTimestamp":1751666312,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日汤臣倍健股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来汤臣倍健股份有限公司新申请注册商标101件，截止目前公司共持有注册商标7918件，另有360件商标尚在注册申请中。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目46次；财产线索方面有商标信息5463条，专利信息679条，著作权信息51条；此外企业还拥有行政许可849个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070500005264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0107","BK0226","BK0146","BK0042","300146","BK0028"],"gpt_icon":0},{"id":"2548362300","title":"汤臣倍健：聚焦科技核心竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2548362300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548362300?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:33","pubTimestamp":1751621586,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月04日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在保健品、药品、食养领域，是否有继续扩大产品、并购、全球性、完善商业生态等方面，形成更坚固护城河的趋势？汤臣倍健回复：投资者您好！公司主营膳食营养补充剂，聚焦科技核心竞争力，持续打造与提升产品力、品牌力、渠道力、服务力等核心竞争力，巩固和提升市场领先优势。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400027985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300146","BK0146","BK0028","BK0226","BK0107","BK0042"],"gpt_icon":0},{"id":"2548924008","title":"汤臣倍健：公司将在回购期内实施完成回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2548924008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548924008?lang=zh_cn&edition=full","pubTime":"2025-07-02 20:51","pubTimestamp":1751460710,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司发布了股份回购计划，截止2025年5月底，仅完成2070万元，完成率20.7%，回购截止日期为2025年8月31日，剩下时间不多了，后续你们是否能如期完成回购任务？公司第二期回购计划于2025年8月20日到期，公司将在回购期内实施完成回购计划，具体情况请关注公司公开披露信息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200036413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0146","300146","BK0042","BK0226","BK0107","BK0028"],"gpt_icon":0},{"id":"2547094997","title":"汤臣倍健新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2547094997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547094997?lang=zh_cn&edition=full","pubTime":"2025-06-29 04:54","pubTimestamp":1751144054,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日汤臣倍健股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来汤臣倍健股份有限公司新申请注册商标100件，截止目前公司共持有注册商标7918件，另有359件商标尚在注册申请中。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目46次；财产线索方面有商标信息5462条，专利信息678条，著作权信息51条；此外企业还拥有行政许可849个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900000941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0146","BK0114","BK0226","BK0028","BK0107","BK0042"],"gpt_icon":0},{"id":"2546207978","title":"汤臣倍健成为Nature增刊发布的“全球科技企业”专题唯一VDS企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2546207978","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546207978?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:24","pubTimestamp":1750926240,"startTime":"0","endTime":"0","summary":"6月25日，国际权威科学期刊Nature增刊发布“全球科技企业”专题，汤臣倍健因在精准营养领域的突破性研究成果被重点介绍，是专题中唯一膳食营养补充剂企业。这是继2023年6月登上Nature增刊后，汤臣倍健再次登上国际顶级期刊，不仅印证了全球科学界对中国营养科研实力的认可，更说明汤臣倍健已逐步成为全球VDS行业的领先企业。这项技术突破，被Nature增刊称为“小样本、大数据”式的科研创新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-06-26/doc-infckxse6966259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0226","300146","BK0114","BK0042","BK0107","BK0028"],"gpt_icon":0},{"id":"2545774285","title":"汤臣倍健收盘上涨1.63%，滚动市盈率49.98倍，总市值190.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545774285","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545774285?lang=zh_cn&edition=full","pubTime":"2025-06-24 18:23","pubTimestamp":1750760621,"startTime":"0","endTime":"0","summary":"6月24日，汤臣倍健今日收盘11.19元，上涨1.63%，滚动市盈率PE达到49.98倍，总市值190.32亿元。从行业市盈率排名来看，公司所处的食品饮料行业市盈率平均40.71倍，行业中值31.19倍，汤臣倍健排名第90位。截至2025年一季报，共有9家机构持仓汤臣倍健，其中基金6家、其他3家，合计持股数10810.02万股，持股市值12.57亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/24182351273368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0042","BK0226","BK0146","300146","BK0028","BK0107","BK0114"],"gpt_icon":0},{"id":"2545907455","title":"汤臣倍健新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2545907455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545907455?lang=zh_cn&edition=full","pubTime":"2025-06-23 05:08","pubTimestamp":1750626507,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日汤臣倍健股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来汤臣倍健股份有限公司新申请注册商标95件，截止目前公司共持有注册商标7918件，另有354件商标尚在注册申请中。通过天眼查大数据分析，汤臣倍健股份有限公司共对外投资了39家企业，参与招投标项目46次；财产线索方面有商标信息5462条，专利信息678条，著作权信息51条；此外企业还拥有行政许可849个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300000146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0042","BK0107","300146","BK0114","BK0028","BK0226"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754680949364,"stockEarnings":[{"period":"1week","weight":0.0059},{"period":"1month","weight":0.0438},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.0525},{"period":"1year","weight":0.0219},{"period":"ytd","weight":0.0211}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.0877},{"period":"6month","weight":0.1003},{"period":"1year","weight":0.2666},{"period":"ytd","weight":0.0845}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"71205人(较上一季度减少4.96%)","perCapita":"15869股","listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","registeredCapital":"170084万元","survey":"　　汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司获得134项原料及配方等发明专利。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}